Post-Approval Regulatory Support: Best Practices to Maintain Compliance and Competitive Advantage
Effective post-approval regulatory support ensures sustained compliance, safety, and market advantage through monitoring, change control, labeling updates, vigilance, complaint handling,…
Essential Components of a Winning Medical Device Submission Strategy in North America (FDA and Health Canada)
A winning North American medical device submission strategy requires mastering FDA 510(k), PMA, and Health Canada processes, implementing ISO 13485…
North American Cosmetic Compliance Now: MoCRA, Canadian Hotlist, and State-Level Chemical Bans—Practical Steps for Market Entry
To enter the North American cosmetic market, comply with US MoCRA by registering products, ensuring safety, and following GMPs; meet…
How to Build a Tailored Regulatory Roadmap for Pharmaceutical Approvals in the US and Canada
This guide outlines creating customized regulatory roadmaps for US FDA and Health Canada pharmaceutical approvals, emphasizing tailored strategies, key milestones,…
Health Canada’s Updated NHP Framework: What Changed and How to Protect Your Business
Health Canada's updated NHP regulations enforce stricter labeling, GMP, site licence, and post-market rules, raising compliance risks and costs; partnering…
Best Practices for Building an Effective Medical Device Submission Strategy for the US FDA and Health Canada
Develop a clear FDA and Health Canada submission strategy by understanding 510(k), De Novo, PMA, and licensing pathways, ensuring robust…
From Silos to Synergy: A Practical Blueprint to Integrate Your QMS for Global Compliance
This blueprint guides integrating QMS for global compliance, emphasizing process harmonization, eQMS validation, regulatory navigation (FDA, EU MDR, GMP), robust…
Post-Approval Compliance and Risk Management: What Every RA/QA Leader Must Control in the US and Canada
Post-approval compliance in the US and Canada demands robust risk management, pharmacovigilance, complaint handling, and QMS aligned with FDA and…
